European Basic Pharmaceutical Products Production Value Share by Country (Million Euros)

In 2023, Switzerland dominated the European Basic Pharmaceutical Products production with a value share of €58.47 million, significantly ahead of Italy (€12.1 million) and Spain (€9.99 million). Austria, the United Kingdom, and Germany followed with values of €4.14 million, €2.81 million, and €2.73 million, respectively. Smaller shares were seen in Greece, Belgium, the Netherlands, Portugal, France, Romania, Hungary, Czech Republic, Poland, and Serbia, indicating a diverse but concentrated market in a few leading countries.

The year-on-year variation has shown mixed trends: Switzerland (6.98%) and Germany (5.92%) displayed stable growth, while Italy (3.91%) and Spain (3.58%) maintained a moderate increase. Notable spikes were observed in Greece (18.65%), Belgium (42.58%), and the Netherlands (30.61%), whereas the United Kingdom (-6.62%) and France (-20.78%) experienced declines. Despite minimal movements in Romania (3.19%), Hungary (3.2%), Czech Republic (-0.014%), Poland (1.01%), and Serbia (8.83%), the overall industry showcased resilience and potential for growth.

Future trends to watch include potential market shifts with continued innovation and investment in pharmaceuticals. The remarkable growth in Belgium and the Netherlands suggests emerging new hubs. The decline in the United Kingdom and France may signal restructuring or market repositioning. Emerging markets such as Greece and Serbia might further improve their shares with strengthened infrastructure and partnerships.